Marc Beer is the co-founder of Renovia Inc., which is a company that is releasing a series of new products that are aimed at helping those who suffer with pelvic floor disorders. Renovia Inc. is headquartered in Boston and is a medtech company that released its first product, Leva, recently. Leva has gained the approval of the FDA and is a modern pelvic training device that draws on interactive technology to build pelvic strength and to rehabilitate and train pelvic floor muscles. The company plans on helping a lot of people as the disorders it focuses on affect more than 250 million women from all over the world.
The Longwood Fund has invested in Renovia in the Series B round, and this funding will help to test and develop other diagnostic and therapeutic products. Marc Beer commented that his company was overjoyed because of the investment from the Longwood fund and went on to talk about how the money will go towards making millions of women’s lives better. He also talked more about the unique way that joining the company’s proprietary sensor technologies with a solid digital health platform would help their customers to learn more about modern treatments for pelvic floor disorders.
Marc Beer has been working to develop and market biotechnologies, diagnostic devices, and pharmaceuticals for over two and a half decades. He helped to found Renovia with Ramon Iglesias as well as Yolanda Lorié and serves as the company’s CEO. Before this, Marc Beer founded ViaCell and became its CEO. The biotech company focuses on collecting, developing, and preserving umbilical cord blood stem cells. Beer helped to rapidly expand the company until it became a large commercial organization. During his time with the company, it employed over 300 people. ViaCell was eventually sold to PerkinElmer in 2007. During this time period, Marc Beer served Erytech Pharma as a member of its board of directors.
Before working with ViaCell, Marc Beer worked with Genzyme and served as the company’s vice president of global marketing. Before this, he worked in a number of different marketing and sales positions with Abbott Laboratories’ diagnostic and pharmaceutical divisions. He has also served Good Start Genetics as its founding chairman of the board of directors as well as the chairman of the compensation committee. Beer studied at Miami University in Ohio where he earned a Bachelor of Science degree. Today, he continues to work to help those who suffer from specific types of conditions. Learn more : https://www.slideshare.net/MarcBeer